Milestone Pharmaceuticals Inc. · NASDAQ:MIST
Integrated Core Strategies (US) LLC's stake in Milestone Pharmaceuticals Inc. fell to 0.60% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
Integrated Core Strategies (US) LLC's stake in Milestone Pharmaceuticals Inc. fell to 0.60%, 322,082 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 0.60%
- Shares
- 322,082
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 0.60% | 322,082 |
| Millennium Management LLC | 0.60% | 322,082 |
| Millennium Group Management LLC | 0.60% | 322,082 |
| Israel A. Englander | 0.60% | 322,082 |
Source
Related
- Milestone Pharmaceuticals Inc.
- Millennium Management LLC
- Milestone Pharmaceuticals Inc. shareholders
- Schedule 13G · Pavaki Capital Management LLC · Aug 7, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Form 4 · Oliveto Joseph · Apr 20, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Mar 26, 2026